Simplex Trading, LLC Sesen Bio, Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.58 - $0.86 $23,626 - $35,032	-40,736 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$0.73 - $1.28 $68,747 - $120,544	-94,175 Reduced 69.81%	40,736 $33,000
Q3 2021 Oct 28, 2021	BUY	$0.77 - $4.91 $1,178 - $7,512	1,530 Added 1.15%	134,911 $609,000
Q2 2021 Aug 12, 2021	SELL	$2.18 - $4.66 $11,556 - $24,702	-5,301 Reduced 3.82%	133,381 $616,000
Q1 2021 Apr 26, 2021	BUY	$1.3 - $3.24 $118,021 - $294,146	90,786 Added 189.55%	138,682 $360,000
Q4 2020 Feb 02, 2021	BUY	$1.01 - $1.77 $48,374 - $84,775	47,896 New	47,896 $64,000
Q2 2020 Jul 13, 2020	SELL	$0.52 - $0.87 $9,564 - $16,001	-18,393 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$0.39 - $1.03 $3,876 - $10,238	9,940 Added 117.59%	18,393 $10,000
Q4 2019 Feb 05, 2020	BUY	$0.89 - $1.5 $308 - $520	347 Added 4.28%	8,453 $8,000
Q3 2019 Oct 15, 2019	BUY	$1.04 - $1.51 $8,430 - $12,240	8,106 New	8,106 $9,000
Q2 2019 Jul 26, 2019	SELL	$0.95 - $2.46 $24 - $63	-26 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$0.69 - $1.47 $17 - $38	26 New	26 $0

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.